Th-17 cytokines and interstitial lung involvement in systemic sclerosis

Journal of Breath Research

Volumn 10, Issue 4, 2016, Pages

  Rolla, G ^a   Fusaro, E ^b   Nicola, S ^a   Bucca, C ^a   Peroni, C ^b   Parisi, S ^b   Cassinis, M C ^c   Ferraris, A ^c   Angelino, F ^c   Heffler, E ^a   Boita, M ^a   Brussino, L ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; CYTOKINE; IL17A PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INTERSTITIAL LUNG DISEASE; LIMIT OF DETECTION; LUNG DIFFUSION CAPACITY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIX MINUTE WALK TEST; SYSTEMIC SCLEROSIS; TH17 CELL; BREATH ANALYSIS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREATH TESTS; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-17; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 85008467254     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/10/4/046013     Document Type: Article

References (31)

1. Gabrielli A, Avvedimento E V and Krieg T 2009 Scleroderma New Engl. J. Med. 360 1989-2003
2. Meloni F, Solari N, Cavagna L, Morosini M, Montecucco C M and Fietta A M 2009 Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis Clin. Exp. Rheumatol. 27 765-72
3. De Santis M et al 2012 Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease Clin. Respir. J. 6 9-17
4. Schmidt K et al 2009 Bronchoalveolar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients Arthritis Res. Ther. 11 R111
5. Aschner Y et al 2014 Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness Am. J. Pathol. 184 1489-502
6. Fiorentino D F, Bond M W and Mosmann T R 1989 Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J. Exp. Med. 170 2081-95
7. Kubáň P and Foret F 2013 Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review Anal. Chim. Acta 17 1-18
8. Hunt J 2007 Exhaled breath condensate - an overview Immunol. Allergy Clin. North Am. 27 587-96
9. Pleil J D et al 2008 Volatile polar metabolites in exhaled breath condensate (EBC): collection and analysis J. Breath Res. 2 026001
10. Edmé T et al 2008 Cytokine concentrations in exhaled breath condensates in systemic sclerosis Inflamm. Res. 57 151-6
11. Brussino L et al 2014 Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer J. Breath Res. 8 027110
12. Borrill Z L, Roy K and Singh D 2008 Exhaled breath condensate biomarkers in COPD Eur. Respir. J. 32 472-86
13. Kastelijn E A, Rijkers G T, Van Moorsel C H, Zanen P, Kwakkel-van Erp J M, Van De Graaf E A, Van Kessel D A, Grutters J C and Van Den Bosch J M 2010 Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome J. Heart Lung Transplant. 29 997-1008
14. Gannot G, Tangrea M A, Richardson A M, Flaig M J, Hewitt S M, Marcus E M, Emmert-Buck M R and Chuaqui R F 2007 Layered expression scanning: multiplex molecular analysis of diverse life science platforms Clin. Chim. Acta 376 9-16
15. Horvath I et al 2005 Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J. 26 523-48
16. Warrick J H, Bhalla M, Schabel S I and Silver R M 1991 High resolution computed tomography in early scleroderma lung disease J. Rheumatol. 18 1520-8
17. American Thoracic Society 2002 ATS statement: guidelines for the 6 min walk test Am. J. Respir. Crit. Care Med. 166 111-7
18. American Thoracic Society 1978 Recommended standardized procedures for pulmonary testing Am. Rev. Respir. Dis. 118 55-72
19. American Thoracic Society 1987 Standardization of spirometry: 1987 update Am. Rev. Respir. Dis. 136 1285-98
20. American Thoracic Society 1995 Single breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique: 1995 update Am. J. Respir. Crit. Care Med. 152 2185-98
21. Quanjer P H 1983 Standardized lung function testing Bull. Eur. Physiopathol. Respir. 19 45-51
22. Cotes J E, Chinn D J, Quanjer H, Roca J and Yernault J C 1993 Measurement of the transfer factor (diffusing capacity) for the lung and its subdivisions Eur. Respir. J. 6 41-52
23. Long J S and Freese J 2006 Regression Models for Categorical Dependent Variables Using Stata 2nd edn (College station, Texas: Stata Press) pp 223-92
24. Rabe-Hesketh S and Skrondal A 2005 Multilevel and Longitudinal Modeling Using Stata (College Station, TX: Stata Press)
25. Stiegel M A et al 2015 Analysis of inflammatory cytokines in human blood, breath condensate, and urine using a multiplex immunoassay platform Biomarkers 20 35-46
26. Pleil J D, Angrish M M and Madden M C 2015 Immunochemistry for high-throughput screening of human exhaled breath condensate (EBC) media: implementation of automated Quanterix SIMOA instrumentation J. Breath Res. 9 047108
27. Gasse P et al 2011 IL-1 and IL-23 mediate early IL-17a production in pulmonary inflammation leading to late fibrosis after lung injury Plos One 6 e23185
28. Wilson M S et al 2010 Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent J. Exp. Med. 207 535-52
29. Su Mi et al 2011 Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-b1-dependent and -independent mechanisms J. Immunol. 187 3003-14
30. Sziksz E et al 2015 Fibrosis related inflammatory mediators: role of the IL-10 cytokine family Mediators Inflamm. 2015 1-15
31. Alhamad E H, Cal J G, Shakoor Z, Almogren A and AlBoukai A A 2013 Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis BMC Med. Genet. 14 66-75